Clarivate's quarterly revenue has contracted, with 2026Q3 sales falling 22.7% year over year to $481.6M, while gross margin held near 71.1%, suggesting cost of revenue is shrinking in step with the top line.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 3, 2026 | $0.21+18.5% vs $0.18 | $444M-21.6% vs $567M |
Q3 2026 Jul 29, 2026 | $0.19+4.6% vs $0.18 | $587M-0.4% vs $590M |
Q2 2026 Apr 29, 2026 | $0.18+28.6% vs $0.14 | $586M+2.8% vs $569M |
Q1 2026 Feb 24, 2026 | $0.20+25.0% vs $0.16 | $617M+2.0% vs $605M |
Clarivate Demonstrates Global Demand For AI-native Web Of Science Research IntelligencePR NewswireLONDON, Oct. 22, 2026More than 100 institutions across 25 coun
Shares of Clarivate PLC (NYSE: CLVT - Get Free Report) have been assigned a consensus rating of "Reduce" from the eight research firms that are currently covering the firm, MarketBeat Ratings reports. Three investment analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating
WASHINGTON--(BUSINESS WIRE)--Sterne, Kessler, Goldstein & Fox (Sterne Kessler), a market leading intellectual property (IP) law firm, today announced a co-development partnership with Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, to develop AI-enhanced patent workflow solutions. This partnership brings together Sterne Kessler's practitioner-built technology and deep patent practice expertise with Clarivate's leading IP data and software. Together, the.
Transaction sharpens strategic focus on leading Academia & Government and Intellectual Property segments Proceeds strengthen balance sheet and enhance financial flexibility LONDON, Oct. 6, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate" or the "Company"), a leading global provider of transformative intelligence, today announced the successful completion of the sale of its Life Sciences & Healthcare segment to Altaris, LLC ("Altaris"), advancing Clarivate's transformation and simplifying its portfolio. The transaction for $600 million was previously announced on July 6, 2026.
Benchmark CLVT against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Clarivate Plc (CLVT)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $2.34 | $1.5B | -3.87 | -3.97% | -17.02% | -8.27% | — | |
| $204.59 | $26.63B | 30.07 | 6.63% | 27.68% | — | 0.88% | |
| $641.01 | $46.6B | 33.49 | 9.51% | 43.87% | — | 1.12% | |
| $112.57 | $49.14B | 30.96 | 3% | 20.02% | 13.69% | 2.08% | |
| $8.42 | $2.83B | 20.39 | -7.55% | 9.15% | — | — | |
| $467.80 | $137.91B | 27.36 | 8.18% | 31.99% | 14.88% | 0.82% |
Clarivate Plc (CLVT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Clarivate Plc (CLVT) SEC filings — annual & quarterly reports (10-K, 10-Q)
Nov 4, 2026·SEC
Nov 3, 2026·SEC
Oct 6, 2026·SEC
Get notified when CLVT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Clarivate Plc (CLVT) stock FAQ — growth, dividends, profitability & financials explained
Clarivate Plc (CLVT) reported $2.27B in revenue over the trailing twelve months. Revenue was $2.46B in fiscal year 2025. That is 168% more than the $917.6M of fiscal year 2017.
Clarivate Plc (CLVT) revenue fell by 9.2% over the trailing twelve months, compared with the twelve months before.
No. Clarivate Plc (CLVT) reported a net loss of $386.5M over the trailing twelve months.
Clarivate Plc (CLVT) had a return on equity (ROE) of -8.3% over the trailing twelve months. A negative ROE means the company lost money over the period.
Clarivate Plc (CLVT) generated $322.3M in free cash flow over the trailing twelve months.
